Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Artivion Inc AORT

Healthcare Medical Devices
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment... see more

Recent & Breaking News (NYSE:AORT)

Artivion Reports Third Quarter 2023 Financial Results

PR Newswire November 2, 2023

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

PR Newswire October 19, 2023

Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin

PR Newswire October 5, 2023

Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting

PR Newswire October 5, 2023

Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference

PR Newswire September 26, 2023

Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

PR Newswire September 14, 2023

Artivion Reports Second Quarter 2023 Financial Results

PR Newswire August 3, 2023

Artivion to Participate in Upcoming Investor Conferences

PR Newswire August 1, 2023

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2023 Financial Results

PR Newswire July 20, 2023

Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter

PR Newswire May 23, 2023

Artivion Reports First Quarter 2023 Financial Results

PR Newswire May 4, 2023

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2023 Financial Results

PR Newswire April 20, 2023

Artivion to Participate in the 22nd Annual Needham Virtual Healthcare Conference

PR Newswire April 10, 2023

Artivion to Participate in the Oppenheimer 33rd Annual Healthcare Conference

PR Newswire March 6, 2023

Artivion Reports Fourth Quarter and Full Year 2022 Financial Results

PR Newswire February 16, 2023

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results

PR Newswire February 2, 2023

Artivion to Participate in Upcoming Investor Conferences

PR Newswire November 8, 2022

Artivion Reports Third Quarter 2022 Financial Results

PR Newswire November 3, 2022

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2022 Financial Results

PR Newswire October 20, 2022

Elizabeth Hoff Joins Artivion Board of Directors

PR Newswire September 29, 2022